Metropolis Healthcare (BOM:542650) LT-Debt-to-Total-Asset : 0.08 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Metropolis Healthcare's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.08.

Metropolis Healthcare's long-term debt to total assets ratio declined from Mar. 2023 (0.10) to Mar. 2024 (0.08). It may suggest that Metropolis Healthcare is progressively becoming less dependent on debt to grow their business.

Metropolis Healthcare LT-Debt-to-Total-Asset Historical Data

The historical data trend for Metropolis Healthcare's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare LT-Debt-to-Total-Asset Chart

Metropolis Healthcare Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.08

0.16

0.10

0.08

Metropolis Healthcare Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.10	-	0.08	-	0.08

Metropolis Healthcare LT-Debt-to-Total-Asset Calculation

Metropolis Healthcare's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	1190.678	/	15550.626
	=	0.08

Metropolis Healthcare's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	1190.678	/	15550.626
	=	0.08

Metropolis Healthcare (BOM:542650) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Metropolis Healthcare LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Metropolis Healthcare (BOM:542650) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (BOM:542650) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

METROPOLIS:India

Address

Hind Cycle Marg, 250-D, Udyog Bhavan, Behind Glaxo, Worli, Mumbai, MH, IND, 400 030

Website

https://www.metropolisindia.com

Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare (BOM:542650) Headlines

No Headlines